First Time Loading...
T

Teva Pharmaceutical Industries Ltd
TASE:TEVA

Watchlist Manager
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Watchlist
Price: 5 870 ILS 0.95% Market Closed
Updated: May 12, 2024

Teva Pharmaceutical Industries Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Teva Pharmaceutical Industries Ltd
Operating Expenses Peer Comparison

Comparables:
TARO
I
INCR
MDWD
R
REKA
C
CSURE

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
T
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Operating Expenses
-$4.4B
CAGR 3-Years
1%
CAGR 5-Years
3%
CAGR 10-Years
4%
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Operating Expenses
-$271.3m
CAGR 3-Years
-20%
CAGR 5-Years
-12%
CAGR 10-Years
-7%
I
InterCure Ltd
TASE:INCR
Operating Expenses
-₪109.5m
CAGR 3-Years
-2%
CAGR 5-Years
-70%
CAGR 10-Years
-26%
Mediwound Ltd
NASDAQ:MDWD
Operating Expenses
-$19.1m
CAGR 3-Years
-5%
CAGR 5-Years
-10%
CAGR 10-Years
-10%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Operating Expenses
-₪74.1m
CAGR 3-Years
-14%
CAGR 5-Years
-8%
CAGR 10-Years
0%
C
Cannassure Therapeutics Ltd
TASE:CSURE
Operating Expenses
-₪6.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Teva Pharmaceutical Industries Ltd's Operating Expenses?
Operating Expenses
-4.4B USD

Based on the financial report for Dec 31, 2023, Teva Pharmaceutical Industries Ltd's Operating Expenses amounts to -4.4B USD.

What is Teva Pharmaceutical Industries Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
4%

Over the last year, the Operating Expenses growth was -4%. The average annual Operating Expenses growth rates for Teva Pharmaceutical Industries Ltd have been 1% over the past three years , 3% over the past five years , and 4% over the past ten years .